Form 4 for AORT ARTIVION, INC.
Accepted 2025-08-28 00:00:00 ET · period of report 2025-08-27 · accession 0001849615-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-28 | 2025-08-27 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | M - OptEx | $11.03 | +18.2K | 82.4K | +28% | +$200.7K |
| D | 2025-08-28 | 2025-08-27 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale+OE | $44.02 | -18.2K | 64.2K | -22% | -$801.2K |
| D | 2025-08-28 | 2025-08-27 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | M - OptEx | $0.00 | -18.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-27 | M | A | 18,200 | $11.03 | 82,400 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-27 | S | D | 18,200 | $44.02 | 64,200 | D | — | — | (F1) Reflects weighted average price. Range of prices were between $43.84 to $44.26. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-08-27 | M | D | 18,200 | $0.00 | 0 | D | $11.03 · 2023-11-08 to 2029-11-08 | 18,200 Common Stock | (F2) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023. |